REPORT ID 6546

EMEA (Europe, Middle East and Africa) Cell-based Assays Market Report 2017

Publish Date
26-Dec-17
Pages
127
Format
Electronic (PDF)

In this report, the EMEA Cell-based Assays market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Cell-based Assays for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Cell-based Assays market competition by top manufacturers/players, with Cell-based Assays sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    BD Medical (US)
    Danaher (US)
    Thermo Fisher Scientific (US)
    General Healthcare (UK)
    Merck KGaA (Germany)
    Perkinelmer (US)
    Charles River Laboratories (US)
    Life Technologies (US)
    Lonza Group (Switzerland)
    Cell Signaling Technology (US)
    Promega (US)
    Cisbio Bioassays (France)
    Discoverx (US)
    Proqinase GmbH (Germany)
    Marine Biological Laboratory (US)
    Biospherix (US)
    Essen Bioscience (US)
    Miltenyi Biotec (Switzerland)
    Bioagilytix Labs (US)
    Cell Biolabs (US)
    Biotek Instruments (US)
    Qgel SA (Switzerland)
    Enzo Life Sciences (Switzerland)
    Aurelia Bioscience (UK)
    Selexis SA (US)

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Consumables
    Instruments
    Services
    Software

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Pharmaceutical & Biotechnology Companies
    Academic & Government Institutions
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Cell-based Assays Market Report 2017
1 Cell-based Assays Overview
    1.1 Product Overview and Scope of Cell-based Assays
    1.2 Classification of Cell-based Assays
        1.2.1 EMEA Cell-based Assays Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Cell-based Assays Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Consumables
        1.2.4 Instruments
        1.2.5 Services
        1.2.6 Software
    1.3 EMEA Cell-based Assays Market by Application/End Users
        1.3.1 EMEA Cell-based Assays Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Pharmaceutical & Biotechnology Companies
        1.3.3 Academic & Government Institutions
        1.3.4 Other
    1.4 EMEA Cell-based Assays Market by Region
        1.4.1 EMEA Cell-based Assays Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Cell-based Assays (2012-2022)
        1.5.1 EMEA Cell-based Assays Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Cell-based Assays Revenue and Growth Rate (2012-2022)

2 EMEA Cell-based Assays Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Cell-based Assays Market Competition by Players/Manufacturers
        2.1.1 EMEA Cell-based Assays Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Cell-based Assays Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Cell-based Assays Sale Price by Players (2012-2017)
    2.2 EMEA Cell-based Assays (Volume and Value) by Type/Product Category
        2.2.1 EMEA Cell-based Assays Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Cell-based Assays Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Cell-based Assays Sale Price by Type (2012-2017)
    2.3 EMEA Cell-based Assays (Volume) by Application
    2.4 EMEA Cell-based Assays (Volume and Value) by Region
        2.4.1 EMEA Cell-based Assays Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Cell-based Assays Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Cell-based Assays Sales Price by Region (2012-2017)

3 Europe Cell-based Assays (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Cell-based Assays Sales and Value (2012-2017)
        3.1.1 Europe Cell-based Assays Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Cell-based Assays Revenue and Growth Rate (2012-2017)
    3.2 Europe Cell-based Assays Sales and Market Share by Type
    3.3 Europe Cell-based Assays Sales and Market Share by Application
    3.4 Europe Cell-based Assays Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Cell-based Assays Sales Volume by Countries (2012-2017)
        3.4.2 Europe Cell-based Assays Revenue by Countries (2012-2017)
        3.4.3 Germany Cell-based Assays Sales and Growth Rate (2012-2017)
        3.4.4 France Cell-based Assays Sales and Growth Rate (2012-2017)
        3.4.5 UK Cell-based Assays Sales and Growth Rate (2012-2017)
        3.4.6 Russia Cell-based Assays Sales and Growth Rate (2012-2017)
        3.4.7 Italy Cell-based Assays Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Cell-based Assays Sales and Growth Rate (2012-2017)

4 Middle East Cell-based Assays (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Cell-based Assays Sales and Value (2012-2017)
        4.1.1 Middle East Cell-based Assays Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Cell-based Assays Revenue and Growth Rate (2012-2017)
    4.2 Middle East Cell-based Assays Sales and Market Share by Type
    4.3 Middle East Cell-based Assays Sales and Market Share by Application
    4.4 Middle East Cell-based Assays Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Cell-based Assays Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Cell-based Assays Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Cell-based Assays Sales and Growth Rate (2012-2017)
        4.4.4 Israel Cell-based Assays Sales and Growth Rate (2012-2017)
        4.4.5 UAE Cell-based Assays Sales and Growth Rate (2012-2017)
        4.4.6 Iran Cell-based Assays Sales and Growth Rate (2012-2017)

5 Africa Cell-based Assays (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Cell-based Assays Sales and Value (2012-2017)
        5.1.1 Africa Cell-based Assays Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Cell-based Assays Revenue and Growth Rate (2012-2017)
    5.2 Africa Cell-based Assays Sales and Market Share by Type
    5.3 Africa Cell-based Assays Sales and Market Share by Application
    5.4 Africa Cell-based Assays Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Cell-based Assays Sales Volume by Countries (2012-2017)
        5.4.2 Africa Cell-based Assays Revenue by Countries (2012-2017)
        5.4.3 South Africa Cell-based Assays Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Cell-based Assays Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Cell-based Assays Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Cell-based Assays Sales and Growth Rate (2012-2017)

6 EMEA Cell-based Assays Manufacturers/Players Profiles and Sales Data
    6.1 BD Medical (US)
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Cell-based Assays Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 BD Medical (US) Cell-based Assays Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Danaher (US)
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Cell-based Assays Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Danaher (US) Cell-based Assays Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Thermo Fisher Scientific (US)
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Cell-based Assays Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Thermo Fisher Scientific (US) Cell-based Assays Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 General Healthcare (UK)
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Cell-based Assays Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 General Healthcare (UK) Cell-based Assays Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Merck KGaA (Germany)
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Cell-based Assays Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Merck KGaA (Germany) Cell-based Assays Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Perkinelmer (US)
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Cell-based Assays Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Perkinelmer (US) Cell-based Assays Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Charles River Laboratories (US)
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Cell-based Assays Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Charles River Laboratories (US) Cell-based Assays Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Life Technologies (US)
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Cell-based Assays Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Life Technologies (US) Cell-based Assays Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Lonza Group (Switzerland)
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Cell-based Assays Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Lonza Group (Switzerland) Cell-based Assays Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Cell Signaling Technology (US)
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Cell-based Assays Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Cell Signaling Technology (US) Cell-based Assays Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Promega (US)
    6.12 Cisbio Bioassays (France)
    6.13 Discoverx (US)
    6.14 Proqinase GmbH (Germany)
    6.15 Marine Biological Laboratory (US)
    6.16 Biospherix (US)
    6.17 Essen Bioscience (US)
    6.18 Miltenyi Biotec (Switzerland)
    6.19 Bioagilytix Labs (US)
    6.20 Cell Biolabs (US)
    6.21 Biotek Instruments (US)
    6.22 Qgel SA (Switzerland)
    6.23 Enzo Life Sciences (Switzerland)
    6.24 Aurelia Bioscience (UK)
    6.25 Selexis SA (US)

7 Cell-based Assays Manufacturing Cost Analysis
    7.1 Cell-based Assays Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Cell-based Assays

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Cell-based Assays Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Cell-based Assays Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Cell-based Assays Market Forecast (2017-2022)
    11.1 EMEA Cell-based Assays Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Cell-based Assays Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Cell-based Assays Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Cell-based Assays Price and Trend Forecast (2017-2022)
    11.2 EMEA Cell-based Assays Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Cell-based Assays Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Cell-based Assays Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Cell-based Assays Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Cell-based Assays Sales Forecast by Type (2017-2022)
    11.7 EMEA Cell-based Assays Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer